Oatzempic, a viral oat-based drink, is being hailed as a natural alternative to weight loss injections. Discover its recipe, benefits, and the expert warnings you need to know before trying it.
Nvidia CEO Jensen Huang unveils the Vera Rubin AI platform at CES 2026, promising a 90% reduction in AI token costs and faster processing for data centres and enterprises.
The 'Oatzempic' drink is trending on TikTok for weight loss. Experts reveal if this oat-based concoction can truly mimic the effects of the prescription drug Ozempic or if it's just another fad.
Novo Nordisk launches oral Wegovy weight-loss drug in the US, priced at $299. The pill, approved in Dec 2025, aims to regain market share from rival Eli Lilly. UK approval expected end-2026.
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
The patent expiry of Novo Nordisk's blockbuster drug semaglutide (Ozempic, Wegovy) opens a massive Rs 50,000+ crore market for Indian generic drugmakers, a new report reveals.
UPERC drastically reduces smart prepaid meter costs in UP, offers instalment plans, and assures refunds for excess charges. A major win for power consumers.
New research reveals bariatric surgery delivers five times more weight loss than GLP-1 drugs like Ozempic over two years. Discover the real-world data and what it means for obesity treatment.
Explore how 2025's weight-loss drug boom in India shifted focus from fitness to thinness, raising concerns about medicalisation, side effects, and societal pressure. Read the full analysis.
Ahmedabad Municipal Corporation's Rs 110 crore plan to restore Subhash Bridge is more expensive than building several new flyovers. Get the full details and cost comparison here.
Avadi city police report a significant decline in violent and property crimes in 2025. Murders fell 21%, chain-snatching 35%, aided by NAFIS tech and strategic policing. Read the full report.
Pune traffic police report a 10.44% rise in average vehicle speed and a 50% drop in severe monthly congestion using low-cost management techniques. Enforcement against violations intensified.
As GLP-1 drugs like Ozempic launched in India, experts warn they are not a magic fix. Sustainable metabolic health requires diet, exercise, and stress management. Learn why.
Explore the social and economic impact of GLP-1 drugs like Ozempic & Mounjaro in India. A ₹1,000 crore market is poised for massive growth. Share your thoughts.
New research reveals GLP-1 weight-loss drugs like Ozempic significantly cut grocery and restaurant spending. Discover the impact on food habits in India and globally.
ICAR-IIMR Ludhiana's successful maize hybrid seed trial in Punjab promises to slash cultivation costs, double farmer income, and reduce dependency on southern India for seeds. Discover how this breakthrough aids local seed production.
US FDA approves Novo Nordisk's daily Wegovy pill, an oral alternative to injections. Priced from $149, it offers 14% average weight loss. Details on cost, side effects, and how it compares to rivals.
Shares of Novo Nordisk surged over 7% after its weight loss drug Wegovy pill received US FDA approval on December 22, 2025. Read the full market impact analysis.
US FDA approves Novo Nordisk's Wegovy Pill, first oral GLP-1 drug for weight loss. Priced at $149/month, it promises wider access and challenges injectable dominance. Read more.
Spanish telecom giant Telefonica SA will cut 5,500 jobs at a $2.9 billion cost, aiming for over $700 million in annual savings. The move follows a trimmed cash flow outlook and a halved dividend. Get the latest business news updates.
Women share harrowing experiences of stopping anti-obesity drugs like Wegovy. Experts warn 60-80% weight returns without a plan. Learn about the side effects and new drugs in India.
Rapid weight loss from GLP-1 drugs like Ozempic is causing 'Ozempic face'—facial thinning & sagging. Learn about prevention, treatments, and the 50% rise in cosmetic procedures. #Beauty #Skincare
Bangladesh's pharma firms have a 2-year head start over Indian giants like Dr Reddy's in exporting generic semaglutide. Delhi HC allows exports, but domestic sales wait until 2026. Explore the competitive landscape.
The Vasai Virar City Municipal Corporation (VVCMC) has initiated a process to cut 10% of its contractual staff to reduce costs. Departments must submit detailed reports by December 17.
Actor Ram Kapoor opens up about his 55kg weight loss journey, battling type-2 diabetes, and his mindset shift. Discover his inspiring health transformation story.
Psyllium husk, dubbed 'Desi Ozempic,' is trending as a natural appetite suppressant. Discover how this common fiber compares to prescription drugs and its role in weight management.
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
Delhi High Court rejects Novo Nordisk's patent plea on semaglutide (Ozempic/Wegovy), preventing 'evergreening'. A win for affordable generics in India, but raises concerns over non-clinical misuse of weight-loss drugs. Read more.
WHO releases first-ever global guidelines for GLP-1 medicines to treat obesity, a chronic disease. Learn about the key recommendations and new mental health warnings from Australia.
Australia's TGA issues a safety warning for GLP-1 drugs like Ozempic, linking them to suicidal thoughts and depression. Over 500,000 users affected. Learn the risks and what patients must do.